Don't Miss This Must-Attend Event!

10+Top-Ranking Plenary Speakers Including Nobel Prize Laureates and Industrial Leaders 6 Tracks with 60+ Optional Workshops Focusing on Drug Discovery and Development 500+ Brilliant Scientific, Tech and Business Presentations Offering You Brainstorms 100+ Scientific Posters Presenting Exciting Research Achievements 100+ Exhibition Booths Showcasing New Products and New Technologies 100+ Business Plan and Investment Opportunities Catching Latest Trend in Drug Discovery 1500+ Attendees Coming from Worldwide to Exchange Ideas, Build New Network and Foster Friendship A Colorful Tech Tour to Ancient Cities, Beijing and Xi'an Leading You to Enjoy 5000 Years of Chinese Historical Miracles, Amazing Culture Events and Delicious Foods

Prof. K. Barry Sharpless The Secret Life of Enzymes 2001 Nobel Laureate in Chemistry, The Scripps Research Institute, USA Dr. Joel C. Barrish , Vice President, Immunology and Metabolic Diseases Chemistry, Bristol-Myers Squibb, USA Dr. Henry L. Niman, President, Founder, Recombinomics, Inc. USA Dr. Andreas Tschirky, Roche's head of R&D in China Wenyan David Shen, Ph.D., Executive Director and Head, Biologics Research and GlycoFi, Merck & Co., Inc

Dr. Ira L. Goldknopf Director of Proteomics, Power3 Medical Products, Inc., USA Dr. Harren Jhoti Chief Executive Officer, Astex Therapeutics, Cambridge, UK Dr. Tang Peng Cho Chief Scientific Officer, Shanghai Hengrui Pharmaceuticals, China Dr. Prakash Nagarkatti Associate Dean for Basic Science, University of South Carolina School of Medicine, USA Dr. Mark Engel Chairman, Excel PharmaStudies, China Dr. Shuhui Chen CSO, Wuxi Pharmatech, Shanghai, China Mr. John Oyler President & CEO of BioDuro (Beijing) Company Limited, China Dr.Jing-Shan Hu Director of Merck In-Licensing, China

Plenary Lectures on Medicinal Chemistry -- New Interventions in Drug Discovery: From Bench to Clinic Special Symposium Sponsored by ACS-Medichem Division Time: October 19, 2008 (Sunday Morning) Venue: Ball Room at Loong Palace Hotel, Beijing, China Plenary Lectures Title: The Discovery and Development of SPRYCEL? (Dasatinib) Dr. Joel C. Barrish, Vice President of Immunology Chemistry and Chemical Synthesis at BMS, USA Title: Discovery of Potent and Orally Bioavailable 11βHSD1 Inhibitors: Scaffold Hopping Approach for Novel Lead Generation Based on Medchem Intuition Dr. Wenqing Yao, Senior Scientist, Incyte, Inc., USA Title: Discovery of Taranabant, a CB1 Inverse Agonist for the Treatment of Obesity Dr. Linus Lin, Senior Research Chemist, Merck, USA Title: The Age of a New Generation of Oral Anticogulants. The Discovery of Apixaban, a Potent, Selective and Orally Bioavailable Inhibitor of Coagulation Factor Xa Dr. Donald Pinto, Bristol-Myers Squibb, USA Panel Discussion Panelists: Dr. Joe Shih (Lilly, USA); Dr. Joel C. Barrish (BMS); Dr. Yanping Xu (Lilly);                  Dr. Wenqing Yao (Incyte); Dr. Linus Lin (Merck) 1. Panel Speech Topic: The Evolution of Lilly Oncology: From Cytotoxic Agents (Discovery and Development of ALIMTA) to Kinase Inhibitors Dr. Joe Shih, Distinguished Research Fellow, Lilly, USA 2. Panel Speech Topic: TBD Dr. Joel Barrish, Vice President of Immunology Chemistry and Chemical Synthesis at BMS, USA

This year congress will set an Olympian record in sharing Information comparing to those offered by the brother and sister Drug Discovery events organized by other Information Providers. Track 1: Drug Discovery Sciences -Great Thoughts for Deciphering Human Disorders   Track 4: Therapeutics Development for Diseases -Delivering Promises for Future Drugs       Track 2: Frontiers in Medicinal Chemistry -Special Symposium Sponsored by ACS-Medichem Division   Track 5: Nature Product Based Drug Discovery -Mining 5000 Year Nature Pool       Track 3: Drug Discovery Technologies -Speeding Discovery Process with Niches   Track 6: Drug R & D Partnering in China -Integrating Resources from the East

Workshop 1: How to File IND with China SFDA Workshop 2: What Policy Privilege for Foreign Inventor to Develop Biopharmaceuticals in China Workshop 3: Opportunities and Challenges upon Off-Patent Blockbusters Workshop 4: New Paradigm of Alliance/Collaborative Drug Discovery with Academia in China Workshop 5: How to Meet FDA Requirement by Performing Effective Clinical Trials for INDs in China

Why Exhibit? ★ Position your products in front of decision makers ★ Meet with more than 2000 prospects in formal and informal settings ★ Maximize your exhibit dollars ★ Maintain your competitive image with pharmaceutical research scientists internationally ★ Survey data consistently shows exhibitors report the best qualified leads from the IDDST Exhibition ★ IDDST partners with its exhibitors to help them succeed

Scientific Finding on New Targets Enabled Technological Platform Introduce New Analytical Instrument to Scientists New Products for End customers Licensable IP and Business Plans for VC's evaluation Early Stage Drug Candidates for One-to-One Deal Making Late Stage Drug Candidates for Further Trials Academic Scientific Project for Collaborations Job Opportunities for Post-doc/Scientists/Executives CRO & CMO Hunting for Outsourcing Drug Discovery R & D and Drug Candidate

Till now, BIT Life Sciences has established an eternal and global communication platform. We would warmly welcome to submit your supply and demand information which may involve such items as R&D cooperation, investing and financing, product deputy, sales cooperation, talent recruitment, academic cooperation, student enrollment and so on. We would also release and spread your cooperation information to every attendee through all of conferences organized by BIT Life Sciences. What's more, your information and cooperation intention would reach every corner of the world through our website and other media. Submit your cooperation requirements right now, it is totally free!

Dear Colleagues and Friends: On behalf of organizing committee, I cordially invite you to participate in BIT’s 6th Annual Congress of International Drug Discovery Science and Technology (IDDST) with a theme of “One World, One Hope”, taking place on October 18-22, 2008, in Beijing, China. In the past five years, as a leading meeting place for drug discovery in Pacific Rim Region, IDDST, initiated by BIT Life Sciences, has attracted more than 700 world renowned speakers... more...

What's New Conference Guide Thank Merck for the generous sponsorship to IDDST-2008 Thank Roche for the generous sponsorship to the Welcome Banquet of IDDST-2008 Big Pharmas show great enthusiastic about offering New case studies including Merck, Roche, Eli Lily, Arena etc. China Medicinal Biotech Become The Hosting Organizer Chinese Pharmaceutical Association Become The Supporting Organizer ACS-Medichem Sponsor Special Symposium and Target at Chinese Medicinal Chemists, extend to Chinese membership

Call for Sponsorship BIT's 6th IDDST looks forward to welcoming you to Beijing for a stimulating scientific program and secure your position in the industry and reach highly qualified prospects for your products and solutions. Be an IDDST 2008 Sponsor Now!

Hosting Organization Operating Organization Supporters & Co-organizers American Chemical Society Chinese Pharmaceutical Association American Academy of Nanomedicine Gold Sponsor Roche R&D Center (China) Ltd. Silver Sponsor Merck & Co., Inc. Other Sponsors BioDuro Ltd. Beijing Honghui Meditech Co., Ltd. SAS® Software (Bejing) Ltd. Exhibitors KibowBiotech,Inc. pION, Inc., USA Millipore,Inc. Pharmidex Pharmaceutical Services Ltd. Simulations Plus, Inc. Medicilon/MPI Preclinical Research Shanghai PearL Materia Medica Development(Shenzhen) Ltd. Daicel Chiral Technologies(China) Co., Ltd. Accela ChemBio Co.Ltd Wuxi PharmaTech Venturepharm Service CRO Group Beijing East Linden Sciences & Technology Co., Ltd Shenogen Pharma Group   Media Partners